MTCR

Metacrine, Inc.

A clinical-stage biopharmaceutical company developing oral medicines for liver and metabolic diseases, Metacrine works on treatments for conditions like non-alcoholic steatohepatitis (NASH) and diabetes. It was founded in 2015 by scientists from the Salk Institute, and its name blends "meta" (metabolism) with "crine" (secretion), reflecting its focus on metabolic pathways. The company was based in San Diego, California.

No proxy statement recorded.